相关实验视频
Updated: Jun 16, 2026
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
19.4K
型肝炎病毒包裹的非同源配体广泛中和抗体诱导小鼠中的病毒中和血清
Stephen Ian Walimbwa1,2, Shiv Bharadwaj3, Petr Kosztyu1
1Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital, Olomouc, Czechia.
Frontiers in immunology
|August 6, 2025
概括
开发一种肝炎C病毒 (HCV) 疫苗至关重要,因为感染率不断上升,治疗机会有限. 研究人员创造了新的仿真物,成功地产生了能够中和HCV伪病毒的抗体,为疫苗开发带来了希望.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 全球C型肝炎病毒 (HCV) 感染率正在上升,危及消除目标.
- 直接作用抗病毒药物 (DAA) 在获取和有效性方面存在局限性,需要替代策略.
- 通过抗HCV疫苗进行有效的预防对于对抗持久感染和并发症至关重要.
研究的目的:
- 为了确定新型肝炎C病毒 (HCV) 候选疫苗.
- 开发模拟广泛中和抗体 (bNAbs) 的表位体的非同源模拟物.
- 评估这些仿真物对HCV的免疫性和中和能力.
主要方法:
- 使用组合的Myomedin-loop支架库来发现HCV E2特定的bNAb结合剂.
- 选择了SHB和WIN作为非亲属的仿真物种,以bNAb类仿真物种为目标.
- 免疫小鼠使用选择的仿原体和修改的蛋白质体产生中和抗体.
主要成果:
- 确定了与HCV E2糖蛋白结合的SHB和WIN仿原体.
- 在小鼠中引起的抗体与HCV E2结合并中和HCV伪型病毒.
- 接种WIN和SHB免疫的小鼠表现出各种HCV伪病毒的广泛中和,使用蛋白质体配方改善了结果.
结论:
- 新型非同源的仿原体可以有效地引起广泛的抗HCV中和抗体.
- 这种方法显示出开发具有广泛保护性的HCV疫苗的巨大潜力.
- 为了预防HCV,需要进一步开发这些基因基的免疫原体.
相关概念视频
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...